Burgel PR, Sermet-Gaudelus I, Girodon E, Kanaan R, et al. Gathering real-world compassionate data to expand eligibility for elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis with N1303K or other rare CFTR variants: a viewpoint. Eur Respir J 2024;63:2301959.
PMID: 38242629